Get started
Author

Mai Uesugi

OpenAlex ID: A5112905096
Splicing factor SF3b as a target of the antitumor natural product pladienolide
2007 · Yoshihiko Kotake, Koji Sagane, et al. · Nature Chemical Biology · 664
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2 -Mutant Non-Hodgkin Lymphoma
2014 · Sarah K. Knutson, Satoshi Kawano, et al. · Molecular Cancer Therapeutics · 547
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
2017 · Taisuke Uehara, Yukinori Minoshima, et al. · Nature Chemical Biology · 395
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
2014 · Yasuhiro Funahashi, Kiyoshi Okamoto, et al. · Cancer Science · 273
PDF
Human HRD1 protects against ER stress‐induced apoptosis through ER‐associated degradation1
2002 · Masayuki Kaneko, Masataro Ishiguro, et al. · FEBS Letters · 215
PDF
Suppressive effects of 4‐phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress
2006 · Kyoko Kubota, Yoshifumi Niinuma, et al. · Journal of Neurochemistry · 176
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2021 · Kazuhiko Yamada, Yusaku Hori, et al. · Cancer Research · 71
Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes
2013 · Mai Uesugi, Atsuko Ojima, et al. · Journal of Pharmacological and Toxicological Methods · 48
N-type Calcium Channel in the Pathogenesis of Experimental Autoimmune Encephalomyelitis*
2010 · Naoki Tokuhara, Kana Namiki, et al. · Journal of Biological Chemistry · 34
Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway
2017 · Takayuki Kimura, Mai Uesugi, et al. · Toxicology and Applied Pharmacology · 31
Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines
2012 · Takayuki Tsujioka, Akira Yokoi, et al. · Experimental Hematology · 29
Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like behaviors in rats based on a microarray and peptidome analysis
2013 · Chihiro Miyamoto Nakazawa, Kohdoh Shikata, et al. · Journal of Receptors and Signal Transduction · 23
Chronic Probucol Treatment Decreases the Slow Component of the Delayed-Rectifier Potassium Current in CHO Cells Transfected With KCNQ1 and KCNE1
2011 · Tomohiko Taniguchi, Mai Uesugi, et al. · Journal of Cardiovascular Pharmacology · 21
Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112)
2021 · Sotaro Motoi, Mai Uesugi, et al. · International Journal of Molecular Sciences · 5
PDF
Abstract A296: Eribulin mesylate suppresses experimental metastasis in the MX-1 human breast cancer model by reversing phenotypic states between epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET).
2013 · Taku Yoshida, Galina Kuznetsov, et al. · Molecular Cancer Therapeutics · 2
Abstract 1413: Eribulin caused re-modeling of tumor vasculature altering gene expression profiling in angiogenesis and Epithelial Mesenchymal Transition (EMT) signaling pathway of host cells within human breast cancer cell (BCC) xenografts in nude mice.
2013 · Junji Matsui, Osamu Toyama, et al. · Cancer Research · 2
Abstract 3830: Eribulin and Paclitaxel differentially affect gene expression profiling of blood vessel cells and in vitro angiogenesis in co-cultures of human endothelial cells with pericytes.
2013 · Sergei I. Agoulnik, Judith L. Oestreicher, et al. · Cancer Research · 2
The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product
2009 · Norimasa Miyamoto, Kana Namiki, et al. · Current Pharmaceutical Biotechnology · 2
Data from Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
2023 · Sarah K. Knutson, Satoshi Kawano, et al.
Supplementary Table 1 from Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
2023 · Sarah K. Knutson, Satoshi Kawano, et al.
PDF
Supplementary Table 2 from Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
2023 · Sarah K. Knutson, Satoshi Kawano, et al.
Supplementary Methods, Figure Legends from Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
2023 · Sarah K. Knutson, Satoshi Kawano, et al.
Supplementary Figures 1 - 6 from Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
2023 · Sarah K. Knutson, Satoshi Kawano, et al.
Data from Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
2023 · Sarah K. Knutson, Satoshi Kawano, et al.
Data from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023 · Kazuhiko Yamada, Yusaku Hori, et al.
Works count: 32
Citation count: 2,540
H-index: 13
I10-index: 13
Year
Topic
Type